Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00552409
What this trial is testing

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Who this might be right for
Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
University of Washington 22
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Post-approval studies (Phase 4)UnknownNCT04127084
What this trial is testing

Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Zhongshan Hospital Xiamen University 70
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT01053936
What this trial is testing

Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 129
Post-approval studies (Phase 4)Study completedNCT02682563
What this trial is testing

Renoprotective Effects of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathies
M.H.H. Kramer 44
Not applicableStudy completedNCT00361023
What this trial is testing

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 25
Post-approval studies (Phase 4)Study completedNCT06224790
What this trial is testing

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Diabetic NephropathiesType 2 Diabetes
Sidrah Lodhi 60
Post-approval studies (Phase 4)Study completedNCT04521049
What this trial is testing

Tubular Markers in Response to Saxagliptin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Beni-Suef University 80
Post-approval studies (Phase 4)UnknownNCT00407680
What this trial is testing

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Who this might be right for
Type 2 Diabetes MellitusHypertension
Kitasato University 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07644520
What this trial is testing

Vitamin D in Diabetic Neuropathy

Who this might be right for
Diabetic Nephropathy Type 2
Tanta University 150
Post-approval studies (Phase 4)Looking for participantsNCT06291155
What this trial is testing

Mechanism of SGLT2 Inhibition in the Kidney

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Michigan 20
Not applicableLooking for participantsNCT07245082
What this trial is testing

Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
National Taiwan University Hospital 2,000
Not applicableUnknownNCT06097351
What this trial is testing

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

Who this might be right for
Diabetic Nephropathy
Yipeng Liu 44
Post-approval studies (Phase 4)Study completedNCT00153088
What this trial is testing

INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Boehringer Ingelheim 527
Post-approval studies (Phase 4)UnknownNCT01743014
What this trial is testing

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2Diabetic NephropathyVascular Disease
AHEPA University Hospital 60
Not applicableStudy completedNCT00774904
What this trial is testing

Adiponectin and Insulin Resistance in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Study completedNCT02345057
What this trial is testing

Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Daiichi Sankyo 365
Not applicableStudy completedNCT03154398
What this trial is testing

Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.

Who this might be right for
Evaluation Thyroid Functions in Diabetic Patient
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT01875341
What this trial is testing

Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.

Who this might be right for
Type 2 DiabetesDiabetic NephropathyHypertension+1 more
Ottawa Hospital Research Institute 16
Next Page